Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Jones

Showing results (671-680 of 818) with videos related to

Pageof 82
Sort By:
Diagnostic Microbiology and Infectious Disease|March 15, 2001
Carbapenem-resistant Serratia marcescens isolates producing Bush group 2f beta-lactamase (SME-1) in the United States: results from the MYSTIC ProgrammeA C Gales, D J Biedenbach, P Winokur, et al.
Journal of Clinical Microbiology|January 27, 2012
Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrataM A Pfaller, M Castanheira, S R Lockhart, et al.
The Journal of Antibiotics|December 1, 1977
Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitinR N Jones, C Thornsberry, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1984
Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acidA L Barry, R N Jones, C Thornsberry, et al.
European Journal of Clinical Microbiology|December 1, 1984
3-0-demethyl fortimicin A: in vitro activity and interpretive zone standards for disk diffusion susceptibility testsA L Barry, R N Jones, C Thornsberry, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1980
Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycinC Thornsberry, A L Barry, R N Jones, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1979
Piperacillin susceptibility tests by the single-disk agar diffusion techniqueA L Barry, C Thornsberry, R E Badal, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1988
Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality controlR N Jones, A L Barry, M Pfaller, et al.
The Journal of Antibiotics|July 1, 1977
BL-S786, a new parenteral cephalosporin. II. In vitro antimicrobial activity comparison with six related cephalosporinsR N Jones, C Thornsberry, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1981
Cefmenoxime (SCE-1365), a new cephalosporin: in vitro activity, comparison with other antimicrobial agents, beta-lactamase stability, and disk diffusion testing with tentative interpretive criteriaP C Fuchs, R N Jones, C Thornsberry, et al.
Pageof 82

Showing results (671-680 of 818) with videos related to

Sort By:
Pageof 82
Diagnostic Microbiology and Infectious Disease|March 15, 2001
Carbapenem-resistant Serratia marcescens isolates producing Bush group 2f beta-lactamase (SME-1) in the United States: results from the MYSTIC ProgrammeA C Gales, D J Biedenbach, P Winokur, et al.
Journal of Clinical Microbiology|January 27, 2012
Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrataM A Pfaller, M Castanheira, S R Lockhart, et al.
The Journal of Antibiotics|December 1, 1977
Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitinR N Jones, C Thornsberry, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1984
Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acidA L Barry, R N Jones, C Thornsberry, et al.
European Journal of Clinical Microbiology|December 1, 1984
3-0-demethyl fortimicin A: in vitro activity and interpretive zone standards for disk diffusion susceptibility testsA L Barry, R N Jones, C Thornsberry, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1980
Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycinC Thornsberry, A L Barry, R N Jones, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1979
Piperacillin susceptibility tests by the single-disk agar diffusion techniqueA L Barry, C Thornsberry, R E Badal, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1988
Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality controlR N Jones, A L Barry, M Pfaller, et al.
The Journal of Antibiotics|July 1, 1977
BL-S786, a new parenteral cephalosporin. II. In vitro antimicrobial activity comparison with six related cephalosporinsR N Jones, C Thornsberry, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1981
Cefmenoxime (SCE-1365), a new cephalosporin: in vitro activity, comparison with other antimicrobial agents, beta-lactamase stability, and disk diffusion testing with tentative interpretive criteriaP C Fuchs, R N Jones, C Thornsberry, et al.
Pageof 82